<h4>Background</h4>Anti-programmed cell death protein 1 and its ligand (anti-PD1/PDL1) have been proposed as a promising therapeutic option for advanced biliary tract cancer (aBTC). This evidence concerns the gene CD274 and biliary tract neoplasm.